image of Coronavirus Disease 2019 (COVID-19)

With the growing concerns of Coronavirus Disease 2019 (COVID-19), we wanted to share valuable resources for prevention, especially during your fertility and/or pregnancy care. The prevention of COVID-19 is of utmost priority to DIRM, as we are taking all preventative measures with both our staff and patients.

Only our Newark office is now open regular hours Monday thru Friday. Our Milford location is open as needed for patient monitoring.

Consultations are via Telemedicine, while  procedures and necessary in-office visits require following the recommended CDC guidelines.

Please call 302.738.4600 x10 to schedule your visit.

The icon to the left will take you directly to the CDC’s COVID-19 website for all the latest details

We are constantly monitoring the daily developments related to the spread and risks of novel coronavirus (COVID-19). Our priority at DIRM always remains the health and safety of our patients as well as our staff. To comply with guidance from CDC, WHO, and local public health authorities we are implementing and enhancing our screening policies and precautions for all patients who enter our office.

Tuesday afternoon, The American Society for Reproductive Medicine (ASRM) official statement included above released the following guidelines and recommendations:

This includes but is not limited to:

  1. Suspend initiation of new treatment cycles, including ovulation induction, intrauterine inseminations (IUIs), in vitro fertilization (IVF) including retrievals and frozen embryo transfers, as well as non-urgent gamete cryopreservation.
  2. Strongly consider cancellation of all embryo transfers whether fresh or frozen.
  3. Continue to care for patients who are currently “in-cycle” or who require urgent stimulation and cryopreservation.
  4. Suspend elective surgeries and non-urgent diagnostic procedures.
  5. Minimize in-person interactions and increase utilization of telehealth.

 Patients who are in the midst of their treatment may continue their current cycle. Our care team will counsel patients who wish to continue this cycle about the risks of achieving a pregnancy at this time.

DIRM will continue to do Telemedicine consults, monitor diagnostic cycles, perform diagnostic procedures in the office and monitor patients who are pregnant. Our decision was made by our clinical team based on the above recommendations from The American Society for Reproductive Medicine (ASRM). ASRM will reevaluate these recommendations on March 30, 2020.

Each patient will be contacted directly to discuss rescheduling options. We greatly appreciate your patience as we attempt to accommodate everyone’s schedule.

We understand that this is disappointing news for our patients, and we are committed to resuming care as soon as safely possible.

We will continue to update patients as changes in the COVID-19 pandemic evolve.